Navigation Links
UCLA's Jonsson Cancer Center Foundation 'Taste for a Cure' Honors Twentieth Century Fox Television Chairmen Dana Walden and Gary Newman
Date:4/29/2009

y, Pazanti & Associates at 310-201-5033. Tickets are $500 per person.

The JCCF, founded in 1945, is the single most important vehicle for raising private funds for cancer research at UCLA. It supports a number of high priority cancer research efforts, focused on converting laboratory discoveries into more effective therapies for cancer patients. UCLA's Jonsson Comprehensive Cancer Center (JCCC) is ranked among the nation's top 10 cancer centers by U.S. News & World Report. The JCCC's dedicated researchers are recognized as international leaders in the discovery of new and better ways to prevent, detect and treat cancer.


'/>"/>
SOURCE The Jonsson Cancer Center Foundation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. American Idol Winner David Cook to Perform at and Jimmy Kimmel to Host Jonsson Cancer Center Foundations Taste for a Cure on June 21
2. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
3. Survival differences by race most apparent in advanced stages of breast cancer
4. MRI finds breast cancer before it becomes dangerous
5. Investigators uncover intriguing clues to why persistent acid reflux sometimes turns into cancer
6. Pathway links inflammation, angiogenesis and breast cancer
7. Radiologists encouraged to look beyond cancer for clinically unseen diseases
8. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
9. Immune deficiency linked to a type of eye cancer
10. Drop in breast cancer incidence linked to hormone use, not mammograms
11. Breast cancer prevention practices vary across Canada
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... GI for Life announced today, that ... prices of their popular nutritional supplements: ColoVite Colon ... Discounts of 40% will be offered for a ... proprietary ColoVite supplement is a scientifically formulated vitamin supplement ... One easy-to-take colon vitamin with ALL the nutrients associated ...
(Date:11/26/2014)... 2014 Call 866-997-4948 (Us-Canada Toll Free) ... the details on sales(at)researchmoz(dot)us , Researchmoz.us announces a ... market 2014" with deep study of the report on ... high blood sugar. The global glucose monitoring market has ... growing number of diabetics in the world. Their numbers ...
(Date:11/26/2014)... 26, 2014 News Facts , ... capabilities at RSNA 2014 in Chicago. The company ... share diagnostic images, photos, videos and documents found ... #8107 will learn more about these innovative medical ... and partner initiatives – that enable more informed ...
(Date:11/26/2014)... -- Teens prescribed anti-anxiety or sleep medications are ... other teens, a new study warns. The ... assessments on teenagers before prescribing these drugs to ... don,t realize the abuse potential," said lead researcher ... Michigan School of Nursing. "These drugs produce highly ...
(Date:11/26/2014)... TUESDAY, Nov. 25, 2014 (HealthDay News) -- Parents need ... from sports concussions, an expert warns. Parents must ... and undergo standard, Dr. David Dodick, chair of the ... the Mayo Clinic College of Medicine in Scottsdale, Ariz. ... news release. Any coach involved with teens ...
Breaking Medicine News(10 mins):Health News:GI For Life Slashes Prices by 40% on Liposomal Vitamin D3 and ColoVite Colon Health Formula for a Limited Time 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 2Health News:Latest Report on Diabetes Market 2014 - Global Market Size, Share, Trends and Forecast by Researchmoz.us 3Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Parents Need to Take Lead on Teen Concussion Prevention 2
... of serious complications drop with intensive therapy, study shows ... controlling blood sugar levels and taking medications that lower ... can significantly reduce their risk of developing the most ... , In a study appearing in the July 27 ...
... , , , , ... DCTH ), a medical technology company developing a minimally invasive drug delivery platform ... the Company,s recent progress. In addition, the Company reported its financial results ... Recent Highlights , , , ...
... , , , ARLINGTON, ... today responded to the article in Pediatrics: ... L. Waag, S. Loff, Use of Di(2-Ethylhexyl)Phthalate-Containing Infusion Systems Increases the Risk ... Total parenteral nutrition - delivery of nutrition intravenously via ...
... , , ATLANTA, ... related to the diagnosis and treatment of infertility with ovulation induction ... emotional, scientific and financial aspects. Discussions include information about age related ... donor sperm or donor eggs. , , ...
... , , , ... California Cardiothoracic Surgery Center specializes in cardiothoracic surgery ... not seem like serious symptoms. In fact, most people brush off ... simple symptoms can be indications of the need for ...
... , DENVER, July 27 ... Blue Shield have come together to offer Chamber members a health ... access to both traditional and alternative medical care. Whether members choose ... more traditional treatment regimens, the Chamber Plan,s BlueFreedom accommodates their healing ...
Cached Medicine News:Health News:Tight Management of Type 1 Diabetes Worth the Effort 2Health News:Tight Management of Type 1 Diabetes Worth the Effort 3Health News:Delcath Systems Provides Update on Progress 2Health News:Delcath Systems Provides Update on Progress 3Health News:Delcath Systems Provides Update on Progress 4Health News:Delcath Systems Provides Update on Progress 5Health News:Delcath Systems Provides Update on Progress 6Health News:Delcath Systems Provides Update on Progress 7Health News:ACC Responds to Study Published in Pediatrics About Phthalate and IV Tubing 2Health News:Southern California Surgical Center (heart411.com) Specializes in Mitral Valve Replacement 2Health News:Anthem Blue Cross and Blue Shield Introduces a Health Insurance Solution With a Special 'Boulder Flair' to Chamber Members 2
(Date:11/26/2014)... Calif. and LONDON , Nov. ... and AstraZeneca (NYSE: AZN ) today announced that ... two doses of brodalumab in more than 1,800 patients with ... both Stelara ® (ustekinumab) and placebo at week 12. ... weight-based analysis group were each shown to be superior to ...
(Date:11/26/2014)... 2014 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... in New York on Wednesday, December ... Dr. Helen Torley , President and Chief Executive Officer, ... be webcast through the "Investors" section of Halozyme,s corporate website ... available for 90 days following the event. To access the ...
(Date:11/24/2014)... , Nov. 24, 2014  CryoLife, Inc. (NYSE: ... company focused on cardiac and vascular surgery, announced today that ... Piper Jaffray Healthcare Conference on Wednesday, December 3, 2014 at ... City . A live webcast of the ... and will feature an overview of the company by ...
Breaking Medicine Technology:Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3
... 2012   AMRI (NASDAQ: AMRI ), ... today the appointment of Ian Shott as President of ... and CEO. In this newly created role, Mr. Shott ... including the company,s site in Wales, United Kingdom, and ...
... 2012  Dr. Barry Edison announces that Barry Edison ... has the Pelleve® Wrinkle Reduction System, a revolutionary ... Dr. Edison uses Pelleve—an advanced radiofrequency technology—because the ... with noticeable results. "I am proud to now ...
Cached Medicine Technology:AMRI Announces President for AMRI Europe 2AMRI Announces President for AMRI Europe 3New Jersey Ophthamologist Now Offers Pelleve Wrinkle Reduction Treatment 2